3.24
-0.28 (-7.95%)
| Penutupan Terdahulu | 3.52 |
| Buka | 3.53 |
| Jumlah Dagangan | 11,663 |
| Purata Dagangan (3B) | 62,570 |
| Modal Pasaran | 123,163,744 |
| Harga / Jualan (P/S) | 49.13 |
| Harga / Buku (P/B) | 4.08 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Jan 2023 |
| Margin Operasi (TTM) | -1,655.72% |
| EPS Cair (TTM) | -1.60 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 135.60% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.98% |
| Nisbah Semasa (MRQ) | 4.23 |
| Aliran Tunai Operasi (OCF TTM) | -47.99 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -24.41 M |
| Pulangan Atas Aset (ROA TTM) | -39.20% |
| Pulangan Atas Ekuiti (ROE TTM) | -91.66% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Orchestra BioMed Holdings, Inc. | Menaik | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 3.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | 1.25 |
|
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| % Dimiliki oleh Orang Dalam | 21.82% |
| % Dimiliki oleh Institusi | 55.50% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 20.00 (Chardan Capital, 517.28%) | Beli |
| Median | 14.00 (332.10%) | |
| Rendah | 12.00 (BTIG, 270.37%) | Beli |
| Purata | 15.33 (373.15%) | |
| Jumlah | 3 Beli | |
| Harga Purata @ Panggilan | 3.85 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Chardan Capital | 01 Apr 2025 | 20.00 (517.28%) | Beli | 3.24 |
| BTIG | 20 Mar 2025 | 12.00 (270.37%) | Beli | 4.35 |
| HC Wainwright & Co. | 10 Mar 2025 | 14.00 (332.10%) | Beli | 3.97 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |